The legislation enforces stringent rules on kratom retailers, including a prohibition on selling these products to individuals under 21 years old. Retailers must disclose specific labeling information indicating that the product is kratom, and they are obligated to maintain safety standards to prevent the sale of adulterated or contaminated kratom products. The act also outlines regulatory fees for product registration, contributing to a structured framework for the kratom market in New Jersey.
Summary
Assembly Bill A1188 establishes the New Jersey Kratom Consumer Protection Act, aiming to regulate the sale and distribution of kratom products within the state. The act provides definitions relevant to kratom, identifying it as a substance derived from the Mitragyna speciosa plant, which has both stimulant and opioid-like effects. The bill seeks to ensure consumer safety through provisions related to product labeling and safety testing requirements established by the Department of Health.
Contention
Notable points of contention surrounding A1188 involve balancing consumer safety and the kratom industry's interests. Proponents argue that the bill will protect consumers from potential health risks associated with unregulated kratom sales. Conversely, critics may contend that heightened regulations could stifle accessibility to kratom products for individuals who use them responsibly. The bill also carries penalties for violations, including civil fines and potential criminal charges for repeated offenses, which may further fuel debate on its implications for small retailers.
Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25